| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,452 |
4,723 |
$258K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,273 |
2,969 |
$102K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,261 |
1,299 |
$96K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,239 |
2,700 |
$57K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
807 |
655 |
$56K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,751 |
1,087 |
$52K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,602 |
2,860 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,677 |
1,551 |
$28K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,856 |
857 |
$19K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
754 |
635 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,262 |
803 |
$5K |
| 87428 |
|
132 |
107 |
$4K |
| 87807 |
|
37 |
29 |
$277.10 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
182 |
133 |
$184.09 |
| 81003 |
|
53 |
37 |
$77.76 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
255 |
172 |
$75.36 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
21 |
14 |
$0.00 |